Stay updated on Pembrolizumab vs Docetaxel in NSCLC: Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab vs Docetaxel in NSCLC: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab vs Docetaxel in NSCLC: Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page’s revision label was updated from v3.5.4 to v3.5.5, indicating a new internal revision was applied. This update does not modify visible study information.
    Difference
    0.1%
    Check dated 2026-06-05T10:37:54.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    Added a new page revision label 'Revision: v3.5.4' and removed the previous 'Revision: v3.5.3'. This indicates a minor update to the page's versioning metadata without altering the study content or available information.
    Difference
    0.1%
    Check dated 2026-05-15T04:14:33.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    The page’s revision label was updated from v3.5.2 to v3.5.3, signaling a minor platform/software update to the study page rather than a change to study content or results. No study data, eligibility criteria, or outcomes are altered by this update.
    Difference
    0.1%
    Check dated 2026-04-30T17:50:06.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    Revision: v3.5.2 is displayed, replacing Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-16T10:43:48.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    Revision: v3.5.0 added and v3.4.3 removed.
    Difference
    0.1%
    Check dated 2026-03-18T17:45:44.000Z thumbnail image
  8. Check
    90 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3; no changes to study details or other visible content.
    Difference
    0.1%
    Check dated 2026-03-11T14:43:15.000Z thumbnail image

Stay in the know with updates to Pembrolizumab vs Docetaxel in NSCLC: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Docetaxel in NSCLC: Clinical Trial page.